As global malaria control and elimination efforts have resulted in the suppression of Plasmodium falciparum infections, low-density Plasmodium falciparum infections present a significant challenge. These infections, frequently characterized as "submicroscopic" or "asymptomatic", contribute to the persistent transmission in endemic regions. Recent advancements in molecular diagnostic methodologies have enhanced the detection of these infections and elucidated the nature of previously unrecognized infections. These infections harbor smaller populations of parasites; however, the risk of disease progression and transmission remains substantial. The observed infections could be an alternative survival mechanism of this parasite. Thus, control measures should be redesigned to address these infections, rather than merely expanding the current tools. This review provides an overview of the issues surrounding the detection and monitoring of these infections and their importance for infected individuals and populations, with further emphasis on control measures for malaria elimination.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.parint.2025.103052 | DOI Listing |
Front Immunol
March 2025
Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Individuals residing in malaria-endemic regions with high disease transmission can develop semi-immunity within five years of age. Although understanding the target of the IgGs in this age group helps discover novel blood-stage vaccine candidates and serological markers, it has not been well elucidated due to limited accessibility to plasmodial antigens and samples. This study presents the first comprehensive analysis of antibody levels in plasma obtained from Burkinabe children (n=80, aged 0 to 5 years) to 1307 proteins expressed by the eukaryotic wheat germ cell-free system.
View Article and Find Full Text PDFInt J Mol Sci
February 2025
Institute of Pharmaceutical Sciences, Pharmacognosy, University of Graz, Beethovenstrasse 8, 8010 Graz, Austria.
Malaria remains a major global health problem that has been exacerbated by the impact of the COVID-19 pandemic on health systems. To combat this, the World Health Organization (WHO) has set a target of driving forward research into innovative treatment methods such as new drugs and vaccines. Quinones, particularly 1,4-naphthoquinones, have been identified as promising candidates for the development of antiprotozoal drugs.
View Article and Find Full Text PDFMolecules
February 2025
University of Münster, Institute of Pharmaceutical Biology and Phytochemistry (IPBP), PharmaCampus Corrensstraße 48, D-48149 Münster, Germany.
() and () are protozoan parasites that cause severe diseases, namely, Human African Trypanosomiasis (HAT) and Malaria. Due to limited treatment options, there is an urgent need for new antiprotozoal drugs. (), a plant belonging to the family Buxaceae, is known as a rich source of aminosteroid alkaloids, and a previous study of our working group already showed that the alkaloid-enriched fraction of aerial parts showed promising activity against protozoan parasites.
View Article and Find Full Text PDFMalar J
March 2025
Department of Tropical Diseases, Faculty of Naval Medicine, Naval Medical University, No.8 Panshan Road, Shanghai, 200433, China.
Background: Understanding the emergence and spread of anti-malarial resistance, particularly to artemisinin and its partner drugs, is essential for eradicating malaria in worldwide. To identify genetic markers associated with susceptibility to common anti-malarial drugs, the in vitro sensitivities of anti-malarial drugs were evaluated, and a genome-wide association study of Plasmodium falciparum susceptibility in vitro to multiple anti-malarial drugs was conducted.
Methods: Genomic DNA from 34 samples of P.
Sci Rep
March 2025
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Human Leukocyte Antigens (HLA) are immunoreceptors that present peptide antigens at the cell surface to T cells as a primary mechanism of immune surveillance. Malaria, a disease associated with the Plasmodium parasite, claims > 600,000 lives per year globally with most deaths occurring in Africa. Development of efficacious prophylactic vaccines or therapeutic treatments for malaria has been hindered by the lack of a basic understanding of the role of HLA-mediated peptide antigen presentation during Plasmodium infection.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!